Understanding how HIV medications enter the brain's protective fluid
Investigations of antiretroviral therapy penetration in cerebrospinal fluid
This study is looking at how well HIV medications can reach the brain and spinal fluid, which is important for treating HIV-related issues like dementia, and it aims to find better ways to help patients get the most effective treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-11030297 on NIH RePORTER |
What this research studies
This research investigates how well antiretroviral therapies penetrate the cerebrospinal fluid, which is crucial for treating HIV-related conditions, including dementia. The study aims to enhance our understanding of medication absorption in the brain, potentially leading to improved treatment strategies. Patients may benefit from this research as it seeks to optimize HIV treatment regimens by ensuring effective drug delivery to the central nervous system. The research is conducted by a team of experts at the University of Nebraska Medical Center, focusing on patient-oriented outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living with HIV, particularly those experiencing cognitive impairments or dementia related to the virus.
Not a fit: Patients who are not living with HIV or do not have related cognitive impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for HIV-related dementia and improve the quality of life for affected patients.
How similar studies have performed: Previous research has shown promising results in understanding drug penetration in the central nervous system, indicating that this approach has potential for success.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Avedissian, Sean — University of Nebraska Medical Center
- Study coordinator: Avedissian, Sean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.